Moderna (MRNA) Net Equity Issued and Repurchased (2018 - 2020)
Moderna's (MRNA) quarterly Net Equity Issued and Repurchased came in at $1.3 billion in Q2 2020, up 136.91% on a QoQ basis from $550.0 million in Q1 2020.
Moderna (MRNA) Net Equity Issued and Repurchased (2018 - 2020) Analysis & Trends
Moderna (MRNA) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $1.3 billion in Q2 2020.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $1.3 billion in Q2 2020; TTM through Mar 2021 was $1.3 billion, a 136.91% increase from a year earlier, with the FY2020 full-year figure at $1.9 billion, changed N/A from the prior year.
- Net Equity Issued and Repurchased for Q2 2020 stood at $1.3 billion, up from $550.0 million in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for MRNA reached as high as $1.3 billion in Q2 2020 and fell as low as $111.6 million in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Moderna | 22.52 Bn | 17.32 Bn | -566.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 1.30 Bn |
| Jun 30, 2020 | 1.30 Bn |
| Mar 31, 2020 | 550.00 Mn |
| Mar 31, 2020 | 550.00 Mn |
| Jun 30, 2018 | 111.58 Mn |
| Jun 30, 2018 | 111.58 Mn |
| Mar 31, 2018 | 549.53 Mn |
| Mar 31, 2018 | 549.53 Mn |